Fortress Biotech Ranked in Top 10 of Deloitte’s 2019 Technology Fast 500™

NEXT STORY
Viome announces scientific collaboration with GSK to research the prevention of specific chronic diseases
PREV STORY
Atreca to Present at Two Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)

author_avatar
NASDAQ Market News

Tiziana Life Sciences Announces Initiation of Clinical Trial in a Secondary Progressive Multiple Sclerosis (SPMS) Patient with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program

author_avatar
NASDAQ Market News

iCAD Announces New Clinical Data on the Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment Demonstrating Positive Results

Multi-center research presented at ASTRO 2018 shows IORT with the Xoft System is safe ...

author_avatar
NASDAQ Market News